NeuroPace Total Liabilities and Share Holders Equity 2020-2024 | NPCE
NeuroPace total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
| NeuroPace Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $95 |
| 2023 | $108 |
| 2022 | $114 |
| 2021 | $134 |
| 2020 | $56 |
| 2019 | $21 |
| NeuroPace Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $95 |
| 2024-09-30 | $96 |
| 2024-06-30 | $94 |
| 2024-03-31 | $99 |
| 2023-12-31 | $108 |
| 2023-09-30 | $99 |
| 2023-06-30 | $102 |
| 2023-03-31 | $106 |
| 2022-12-31 | $114 |
| 2022-09-30 | $120 |
| 2022-06-30 | $119 |
| 2022-03-31 | $129 |
| 2021-12-31 | $134 |
| 2021-09-30 | $141 |
| 2021-06-30 | $147 |
| 2021-03-31 | $50 |
| 2020-12-31 | $56 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.392B | $0.080B |
| NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif. | |||